Prostaderm
- Manufacturer
- EZP Corporation | Jinzhou Zijing Pharmaceutical Co. | Jinzhou Zijing Pharmaceutical Co., Ltd.
- Effective date
- 2015-02-24
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:41:51
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredients Purpose
Camphor 3%...........................External analgesic
OTC - PURPOSE SECTION
Uses For the temporary relief of pain
OTC - WHEN USING SECTION
When using this product
- Do not exceed recommended dosage
- Do not use otherwise than as directed
- Do not apply to wounds or damaged skin
OTC - ASK DOCTOR/PHARMACIST SECTION
Stop use and ask a doctor if
- condition worsens
- symptoms persist for more than 7 days
- symptoms clear up and occur again within a few days
- excessive irritation of the skin develops
- redness is present
- side effects occur. You may report side effects to FDA at
1–800–FDA–1088.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep this and all drugs out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away
Do not use otherwise than as directed
OTC - QUESTIONS SECTION
- Questions?1-877-806-3569
DOSAGE & ADMINISTRATION SECTION
Directions
- Clean and dry affected area
- Cut open pouch and remove patch
- Remove Protective film and apply directly to the navel vertically
- Do not apply to area with excessive hair. Highly adhesive patch, may hurt skin upon removal
| Adults | Apply to affected area for 24-48 hours |
| Children under 18 years of age | Ask a doctor |
WARNINGS SECTION
For external use only.
Do not use otherwise than as directed
INDICATIONS & USAGE SECTION
Uses For the temporary relief of pain.
INACTIVE INGREDIENT SECTION
Cistanche Deserticola stem, Syzygium aromaticum whole, Commiphora myrrha resin, Corydalis bungeana whole, Dictamnus dasycarps root bark, Foeniculum vulgare whole, Synthetic moschus resin, Polyvinyl alcohol, Glycerol, Laurocapram
Prostaderm PDP
Prostaderm Drug Facts
DailyMed RxNorm Mappings#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 69446-100-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-5a2e-f424-e053-dadaa90a57ce | Prostaderm |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69446-100-01 | Prostaderm | 1 in 1 PACKAGE | PLASTER | 1 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CAMPHOR (SYNTHETIC) | ACTIVE INGREDIENT | 5TJD82A1ET | 1 | |
| CAMPHOR (SYNTHETIC) | ACTIVE MOIETY | 5TJD82A1ET | 1 | |
| CISTANCHE DESERTICOLA STEM | INACTIVE INGREDIENT | 45BEI4ZF64 | 1 | |
| COMMIPHORA MYRRHA WHOLE | INACTIVE INGREDIENT | UU81N77RI7 | 1 | |
| CORYDALIS BUNGEANA WHOLE | INACTIVE INGREDIENT | 732H9A883V | 1 | |
| DICTAMNUS DASYCARPUS ROOT BARK | INACTIVE INGREDIENT | LA97176ILS | 1 | |
| FOENICULUM VULGARE WHOLE | INACTIVE INGREDIENT | J1UK54JBGH | 1 | |
| GLYCEROL FORMAL | INACTIVE INGREDIENT | 3L7GR2604E | 1 | |
| LAUROCAPRAM | INACTIVE INGREDIENT | 1F3X9DRV9X | 1 | |
| MOSCHUS MOSCHIFERUS MUSK SAC RESIN | INACTIVE INGREDIENT | 8KFK4W7KP7 | 1 | |
| POLYVINYL ALCOHOL | INACTIVE INGREDIENT | 532B59J990 | 1 | |
| SYZYGIUM AROMATICUM WHOLE | INACTIVE INGREDIENT | EY9MMA0P6Y | 1 |
Products#
Every source-derived product name is available through these pages.
- Prostaderm
- camphor
- CAMPHOR (SYNTHETIC)
- CISTANCHE DESERTICOLA STEM
- SYZYGIUM AROMATICUM WHOLE
- COMMIPHORA MYRRHA WHOLE
- CORYDALIS BUNGEANA WHOLE
- DICTAMNUS DASYCARPUS ROOT BARK
- FOENICULUM VULGARE WHOLE
- MOSCHUS MOSCHIFERUS MUSK SAC RESIN
- POLYVINYL ALCOHOL
- GLYCEROL FORMAL
- LAUROCAPRAM
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 69446-100 | 69446-100-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| POLYVINYL ALCOHOL | POLYVINYL ALCOHOL | 532B59J990 | SYSTEM / TOPICAL | 420 mg | ||
| POLYVINYL ALCOHOL | POLYVINYL ALCOHOL | 532B59J990 | AEROSOL, FOAM / VAGINAL | 0.5 %w/w | ||
| POLYVINYL ALCOHOL | POLYVINYL ALCOHOL | 532B59J990 | SOLUTION / OPHTHALMIC | 6 mg | ||
| POLYVINYL ALCOHOL | POLYVINYL ALCOHOL | 532B59J990 | TABLET, EXTENDED RELEASE / ORAL | 96 mg | ||
| POLYVINYL ALCOHOL | POLYVINYL ALCOHOL | 532B59J990 | TABLET, COATED / ORAL | 0.7 mg | ||
| POLYVINYL ALCOHOL | POLYVINYL ALCOHOL | 532B59J990 | SOLUTION/ DROPS / OPHTHALMIC | 1.4 %w/v | ||
| POLYVINYL ALCOHOL | POLYVINYL ALCOHOL | 532B59J990 | TABLET / ORAL | 165 mg | ||
| POLYVINYL ALCOHOL | POLYVINYL ALCOHOL | 532B59J990 | TABLET, FILM COATED / ORAL | 20 mg | ||
| POLYVINYL ALCOHOL | POLYVINYL ALCOHOL | 532B59J990 | CAPSULE / ORAL | 1.67 mg | ||
| POLYVINYL ALCOHOL | POLYVINYL ALCOHOL | 532B59J990 | IMPLANT / INTRAVITREAL | 0.12 mg | ||
| POLYVINYL ALCOHOL | POLYVINYL ALCOHOL | 532B59J990 | SUSPENSION / OPHTHALMIC | 1.4 %w/w | ||
| POLYVINYL ALCOHOL | POLYVINYL ALCOHOL | 532B59J990 | SOLUTION / TOPICAL | 1.4 %w/v | ||
| POLYVINYL ALCOHOL | POLYVINYL ALCOHOL | 532B59J990 | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/v | ||
| POLYVINYL ALCOHOL | POLYVINYL ALCOHOL | 532B59J990 | SUSPENSION/ DROPS / OPHTHALMIC | 1.4 %w/v | ||
| POLYVINYL ALCOHOL | POLYVINYL ALCOHOL | 532B59J990 | SUSPENSION / ORAL | 5 mg | ||
| POLYVINYL ALCOHOL | POLYVINYL ALCOHOL | 532B59J990 | CREAM / VAGINAL | 0.5 %w/w | ||
| POLYVINYL ALCOHOL | POLYVINYL ALCOHOL | 532B59J990 | TABLET, ORALLY DISINTEGRATING / ORAL | 2 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a2d1609e-8274-4e19-855f-03a787a3888c | b6fe33fa-8c06-4280-be21-b5319dab990a | 2015-02-24 | Warnings | a2d1609e-8274-4e19-855f-03a787a3888c b6fe33fa-8c06-4280-be21-b5319dab990a |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

